Skip to main content

J&J COVID-19 vaccine protects monkeys in a single dose

COVID-19 vaccine Johnson

CHICAGO: Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.

When exposed to the virus, six out of six animals who got the candidate vaccine were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published in the journal Nature.

“This gives us confidence that we can test a single-shot vaccine in this epidemic and learn whether it has a protective effect in humans,” Dr. Paul Stoffels, J&J’s chief scientific officer, told Reuters in a telephone interview.

The U.S. government is backing J&J’s vaccine effort with $456 million in funding as part of a spending spree aimed at speeding production of a vaccine to end the pandemic, which has infected millions and killed more than 660,000 people.

Stoffels said prior tests of this type of vaccine in other diseases found that a second shot significantly increases protection. But in a pandemic a single-shot vaccine has a significant advantage, sidestepping a lot of the logistical issues involved in getting people to come back for their second dose.

The company plans to take up the question of one or two doses in its phase 1 trial, which kicked off this week in the United States.

Depending on those results, J&J plans to start large-scale, phase 3 testing with a single-shot regimen in the second half of September. Around the same time, the company will start a parallel phase 3 study testing a two-shot regimen of the vaccine, Stoffels said.

J&J’s vaccine uses a common cold virus known as adnovirus type 26 or Ad26 to ferry coronavirus proteins into cells in the body, causing the body to mount an immune defense against the virus.

In the monkey study, scientists from J&J and Harvard’s Beth Israel Deaconess Medical Center studied seven different potential vaccines in 32 animals and compared the results to 20 control animals who got placebo shots.

Six weeks later, all of the animals were exposed to the SARS-CoV-2 virus. All 20 animals that received the placebo developed high levels of virus in their lungs and nasal swabs.

In the best-performing candidate, which J&J selected for human testing, none of the animals had virus in their lungs and only one showed low levels of virus in nasal swabs. Lab tests showed they all had developed antibodies capable of neutralizing the virus after a single shot.

“This study shows that even just a single immunization with the Ad26 vaccine leads to neutralizing antibody responses and robust protection of monkeys against COVID-19,” said Dr. Dan Barouch, a vaccine researcher at Beth Isreal Deaconness who led the research in collaboration with J&J.

The post J&J COVID-19 vaccine protects monkeys in a single dose appeared first on ARY NEWS.

Labels:

Comments

Post a Comment

Popular posts from this blog

Accountability court hears assets case against Ishaq Dar

ISLAMABAD: An accountability court in Islamabad on Wednesday resumed the hearing of a reference filed against former finance minister Ishaq Dar by the National Accountability Bureau (NAB) for allegedly accumulating assets beyond his known sources of income.  Judge Muhammad Bashir is recording the statement of a prosecution witness, Ishtiaq Ahmed. At the previous hearing, the accountability judge had reserved his verdict on an application filed by two co-accused seeking acquittal in the case. Naeem Mehmood and Mansoor Rizvi, who are directors of Dar’s companies, had filed the application requesting the judge to exonerate them from all charges for want of evidence. Qazi Misbah, the counsel for the two co-accused, contended the prosecution has failed to provide compelling evidence to prove the allegations leveled against his clients. The third co-accused President National Bank of Pakistan (NBP), Saeed Ahmed, had already filed an application before the court for his acquittal wh...
Post a Comment
Read more

SFA raids several restaurants in Karachi, imposes fine

KARACHI: The Sindh Food Authority (SFA) on Friday raided several restaurants in city’s North Nazimabad area over unhygienic conditions, ARY News reported. According to the SFA, one of the restaurants was found utilizing the used oil multiple times. The items were also not properly frozen while crockery for serving the food was also not clean. The team imposed a fine of Rs 50,000 on the restaurant. The SFA team found hygiene standards were sheerly compromised in food making to the core. The food inspectors said they had previously served notices to the food outlets, but the restaurant owners apparently turned a blind eye to it. Raids were also conducted in district Malir and Gulshan-e-Hadeed. Sanitary conditions and lack of fumigation facilities were found at the restaurants in some of the Malir outlets. The SFA team also raided a bakery ‘Friend Bakers’ and imposed a fine of Rs 20,000 over poor hygiene.  Similarly another roadside restaurant was fined Rs 20,000 for neglecting he...
Post a Comment
Read more

Trump says US generals feel Beirut blast was likely an ‘attack’

WASHINGTON: President Donald Trump on Tuesday cast a massive explosion in Beirut as a possible attack, despite statements by Lebanese leaders that it was likely caused by highly explosive material that had been stored at warehouses in the capital for years. “The United States stands ready to assist Lebanon,” Trump said at a White House briefing of Tuesday’s explosion, which killed at least 78 people and injured thousands. “It looks like a terrible attack.” When asked later about his depiction of the explosion, Trump said that he had met with some U.S. generals who feel the blast was not “some kind of a manufacturing explosion type of event.” He told reporters that according to these unnamed generals “they seem to think it was an attack. It was a bomb of some kind.” The Pentagon referred questions to the White House. Two U.S. officials, speaking on the condition of anonymity, said it was unclear where Trump was receiving his information but that initial information did not appear...
Post a Comment
Read more